164 related articles for article (PubMed ID: 10991930)
1. Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.
Ho M; Corbett AD; McKnight AT
Br J Pharmacol; 2000 Sep; 131(2):349-55. PubMed ID: 10991930
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
Mason SL; Ho M; Nicholson J; McKnight AT
Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
Flau K; Redmer A; Liedtke S; Kathmann M; Schlicker E
Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.
Sbrenna S; Marti M; Morari M; Calo' G; Guerrini R; Beani L; Bianchi C
Br J Pharmacol; 2000 May; 130(2):425-33. PubMed ID: 10807682
[TBL] [Abstract][Full Text] [Related]
5. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-RYYRIK-NH(2) is a highly efficacious OP(4) receptor agonist in the cardiovascular system of anesthetized rats.
Malinowska B; Kozłowska H; Berger H; Schlicker E
Peptides; 2000 Dec; 21(12):1875-80. PubMed ID: 11150649
[TBL] [Abstract][Full Text] [Related]
7. ORL-1 receptor mediates the action of nociceptin on ascending myenteric reflex pathways in rats.
Yüce B; Sibaev A; Haaken A; Saur D; Allescher HD; Göke B; Timmermans JP; Storr M
Gastroenterology; 2007 Aug; 133(2):574-86. PubMed ID: 17681177
[TBL] [Abstract][Full Text] [Related]
8. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
[TBL] [Abstract][Full Text] [Related]
9. Pre- and postsynaptic inhibition by nociceptin in guinea pig small intestinal myenteric plexus in vitro.
Liu S; Hu HZ; Ren J; Gao C; Gao N; Lin Z; Xia Y; Wood JD
Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G237-46. PubMed ID: 11408277
[TBL] [Abstract][Full Text] [Related]
10. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane-anaesthetized rats.
Albrecht D; Blühdorn R; Siegmund H; Berger H; Calo' G
Br J Pharmacol; 2001 Sep; 134(2):333-42. PubMed ID: 11564651
[TBL] [Abstract][Full Text] [Related]
12. ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery.
Bucher B
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):682-5. PubMed ID: 9879729
[TBL] [Abstract][Full Text] [Related]
13. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
[TBL] [Abstract][Full Text] [Related]
14. L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.
Sbrenna S; Marti M; Morari M; Calo G; Guerrini R; Beani L; Bianchi C
J Pharmacol Exp Ther; 1999 Dec; 291(3):1365-71. PubMed ID: 10565862
[TBL] [Abstract][Full Text] [Related]
15. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro.
Connor M; Vaughan CW; Jennings EA; Allen RG; Christie MJ
Br J Pharmacol; 1999 Dec; 128(8):1779-87. PubMed ID: 10588934
[TBL] [Abstract][Full Text] [Related]
17. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin.
Ahmadi S; Liebel JT; Zeilhofer HU
Eur J Pharmacol; 2001 Jan; 412(1):39-44. PubMed ID: 11166734
[TBL] [Abstract][Full Text] [Related]
18. [Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.
Rizzi A; Bigoni R; Caló G; Guerrini R; Salvadori S; Regoli D
Eur J Pharmacol; 1999 Dec; 385(2-3):R3-5. PubMed ID: 10607891
[TBL] [Abstract][Full Text] [Related]
19. [Nphe(1)]nociceptin-(1-13)NH(2) selectively antagonizes nociceptin effects in the rabbit isolated ileum.
Pheng LH; Calo G; Guerrini R; Regoli D
Eur J Pharmacol; 2000 Jun; 397(2-3):383-8. PubMed ID: 10844138
[TBL] [Abstract][Full Text] [Related]
20. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
